Clinical trial
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial
NCT04031833 is registered in ClinicalTrials.gov with Matinas BioPharma Nanotechnologies, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial
- Lead sponsor
- Matinas BioPharma Nanotechnologies, Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 24, 2019
- Completion date
- February 15, 2023
- Enrollment
- 178 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cryptococcal meningitis